On 17 April 2026, Jinxin Fertility Group's quality and safety team visited Wuhan Jinxin for a focused review. The hospital's management and department leads accompanied the inspection.
The review covered medical administration, nursing, infection control, pharmacy, laboratory medicine and ultrasound. Topics included clinical documentation, patient identification, medicines, equipment calibration and report verification.
The team recognized progress and identified opportunities to improve processes. Hospital management said it would review the recommendations and incorporate corrective actions into ongoing quality management.
JINXIN · CARE CONTINUESBack to News